Evolving gene therapy approaches for osteosarcoma using viral vectors: Review
- 26 December 2006
- Vol. 40 (4), 797-812
- https://doi.org/10.1016/j.bone.2006.10.017
Abstract
No abstract availableKeywords
This publication has 153 references indexed in Scilit:
- Dangerous liaisons: the role of “danger” signals in the immune response to gene therapyBlood, 2002
- Gene therapy for meningioma: improved gene delivery with targeted adenovirusesJournal of Neurosurgery, 2002
- Growth suppression of established human osteosarcoma lung metastases in mice by aerosol gene therapy with PEI– p53 complexesCancer Gene Therapy, 2001
- Combination treatment for osteosarcoma with baculoviral vector mediated gene therapy (p53) and chemotherapy (adriamycin)Experimental & Molecular Medicine, 2001
- Efficacy of a replication-selective adenovirus against ovarian carcinomatosis is dependent on tumor burden, viral replication and p53 statusGene Therapy, 2000
- Adenovirus-Mediated Gene Therapy of Osteoblasts In Vitro and In VivoJournal of Bone and Mineral Research, 1999
- Limb Salvage and Outcome of OsteosarcomaPublished by Wolters Kluwer Health ,1999
- Alterations of thep53, Rb andMDM2 genes in osteosarcomsZeitschrift für Krebsforschung und Klinische Onkologie, 1996
- Regional Delivery of an Adenovirus Vector Containing the Escherichia coli Cytosine Deaminase Gene to Provide Local Activation of 5-Fluorocytosine to Suppress the Growth of Colon Carcinoma Metastatic to LiverHuman Gene Therapy, 1996
- Integrins αvβ3 and αvβ5 promote adenovirus internalization but not virus attachmentCell, 1993